EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies

Carolina S Marques iD, Pedro Brandão iD, Anthony J Burke

Molecules · 13.11.2024 · 29 (22) · 5341

DOI: 10.3390/molecules29225341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 13.11.2024. Verfasst von Carolina S Marques und 2 weiteren Autor:innen. Beteiligte Einrichtung: LAQV-REQUIMTE, Institute for Research and Advanced Training, University of Évora, Rua Romão Ramalho, 59, 7000-641 Evora, Portugal. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Protein Kinase Inhibitors. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial growth factor receptor 2 (VEGFR-2) is a crucial mediator of angiogenesis, playing a pivotal role in both normal physiological processes and cancer progression. Tumors harness VEGFR-2 signaling to promote abnormal blood vessel growth, which is a key step in the metastasis process, making it a valuable target for anticancer drug development. While there are VEGFR-2 inhibitors approved for therapeutic use, they face challenges like drug resistance, off-target effects, and adverse side effects, limiting their effectiveness. The quest for new drug candidates with VEGFR-2 inhibitory activity often starts with the selection of key structural motifs present in molecules currently used in clinical practice, expanding the chemical space by generating novel derivatives bearing one or more of these moieties. This review provides an overview of recent advances in the development of novel VEGFR-2 inhibitors, focusing on the synthesis of new drug candidates with promising antiproliferative and VEGFR-2 inhibition activities, organizing them by relevant structural features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2Protein Kinase InhibitorsHumansAntineoplastic AgentsNeoplasmsAnimalsAngiogenesis InhibitorsSignal TransductionStructure-Activity RelationshipNeovascularization, Pathologic

Stichwörter der Autor:innen

5-member heterocycle6-member heterocycleVEGFR-2coumarininhibitorsisatinthioureaurea

Substanzen

Vascular Endothelial Growth Factor Receptor-2Protein Kinase InhibitorsAntineoplastic AgentsKDR protein, humanAngiogenesis Inhibitors

Autor:innen und Institutionen

  • LAQV-REQUIMTE, Institute for Research and Advanced Training, University of Évora, Rua Romão Ramalho, 59, 7000-641 Evora, Portugal.
  • Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, Campus Universitátio, Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
  • Centro de Química de Coimbra, Institute of Molecular Sciences (CQC-IMS), Departamento de Química, Faculdade de Ciências e Tecnologia, University of Coimbra, 3004-535 Coimbra, Portugal.
  • iBB-Institute for Bioengineering and Biosciences, Department of Bioengineering, Associate Laboratory i4HB-Institute for Health and Bio-Economy, Instituto Superior Técnico, University of Lisboa, Av. Rovisco Pais, 1049-00…
  • Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal.

ORCID-Profile: Carolina S Marques, Pedro Brandão

Förderung

  • Fundação para a Ciência e Tecnologia
  • Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES)

Zitieren

APA

Marques, C. S., Brandão, P., & Burke, A. J. (2024). Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies. Molecules, 29(22), 5341. https://doi.org/10.3390/molecules29225341

Vancouver

Marques CS, Brandão P, Burke AJ. Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies. Molecules. 2024;29(22):5341. doi:10.3390/molecules29225341

BibTeX
@article{Marques2024,
  author = {Marques, Carolina S and Brandão, Pedro and Burke, Anthony J},
  title = {Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {22},
  pages = {5341},
  doi = {10.3390/molecules29225341}
}
Kostenlos starten →